1. Search Result
Search Result
Results for "

2044679-53-8

" in MCE Product Catalog:
Cat. No. Product Name Target Research Area
  • HY-P99390
    Tepoditamab

    MCLA 117

    Inhibitory Antibodies Cancer
    Tepoditamab (MCLA-117) is a bispecific monoclonal antibody that binds to CLEC12A of myeloid cells and CD3 of cytotoxic T cells. Among others, CLEC12A is a myeloid differentiation antigen. Tepoditamab (MCLA-117) kills AML leukaemia mother cells and AML leukaemia stem cells, induces T cell-mediated proliferative lysis of AML cells and can be used in acute myeloid leukaemia (AML) research.